Press Archive - Stand Up To Cancer

Give Now


Read the latest Stand Up To Cancer press releases and announcements to see how we are making an impact.


July 29, 2020

Stand Up To Cancer Awards $1.1 Million In Grants to Research Teams

Stand Up To Cancer announced today five new awards that will cut across institutional and national lines to foster collaborative research and explore new paths to improve cancer treatment.
Read More
July 27, 2020

Cedric the Entertainer and Stand Up To Cancer Join Forces for a New PSA Campaign to Increase Awareness of Cancer Clinical Trials

Stand Up To Cancer® (SU2C) Ambassador and comedian Cedric the Entertainer has teamed up with SU2C for a new public service announcement (PSA) designed to educate and encourage cancer patients to explore treatment options available through clinical trials.
Read More
July 16, 2020

Stand Up To Cancer Announces New Research and Education Effort Focused on Improving Health Equity for Underserved Lung Cancer Patients

Stand Up To Cancer today announced a new $5 million grant from Bristol Myers Squibb to fund research and education efforts aimed at achieving health equity for underserved lung cancer patients, including Black people and people living in rural communities.
Read More
June 1, 2020

Convenient Spit Test Helps Women Assess Cancer Risk From the Comfort of Their Own Homes

Genetic testing for cancer risk can significantly improve the prevention or treatment of hereditary cancers, but studies have shown that people who might have a genetic risk often don’t get tested.
Read More
May 26, 2020

Stand Up To Cancer Hails FDA Approval of Olaparib for Advanced Prostate Cancer

A recent FDA approval supported by Stand Up To Cancer research provides a new treatment option for patients with an aggressive form of prostate cancer.
Read More
May 20, 2020

Jaime Camil Joins Cancer Survivors in New PSA for Stand Up To Cancer® to Encourage Hispanic Participation in Cancer Clinical Trials

Actor and Stand Up To Cancer (SU2C) Ambassador Jaime Camil has joined forces with cancer survivors in a new public service announcement (PSA) campaign to raise awareness with the Hispanic community about cancer clinical trials.
Read More
April 29, 2020

Stand Up To Cancer Hails FDA Approval of Encorafenib + Cetuximab Combination for Patients with BRAF V600E-Mutant Metastatic Colorectal Cancer

Stand Up To Cancer (SU2C) welcomed the recent Food and Drug Administration (FDA) approval this month of encorafenib in combination with cetuximab for patients with advanced BRAF-mutated colorectal cancer.
Read More
April 27, 2020

Stand Up To Cancer Funded Research To Be Presented During The AACR Virtual Meeting 1 – April 27-28, 2020

Stand Up To Cancer® (SU2C)-supported research will be presented during the American Association for Cancer Research Annual (AACR) Virtual Meeting 10 from April 27th to 28th.
Read More
March 30, 2020

New COVID-19 symptom reasearch app recruiting millions of Americans, including healthcare professionals, cancer patients and survivors, to beat the disease

As the COVID-19 coronavirus pandemic grips the US, a new free app is helping to track the onset and progression of symptoms of millions across the nation. The app will help identify those at risk sooner, and help slow the outbreak of the disease. Information about those who remain symptom-free will also support better understanding of COVID-19.
Read More
March 5, 2020

The Pancreatic Cancer Collective Extends Four Research Teams in $16 Million Push for New Therapies

The Pancreatic Cancer Collective, the strategic partnership of Lustgarten Foundation and Stand Up To Cancer (SU2C), has awarded additional funding of up to $16 million to four teams of top researchers as part of its “New Therapies Challenge Grants,” the American Association for Cancer Research (AACR), Scientific Partner of SU2C, announced today.
Read More


Sign up to receive emails from Stand Up To Cancer.
   Please leave this field empty
Stand Up to Cancer

Thanks for signing up!
You will hear from us soon.